These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 27824617)

  • 1. Tumor-associated macrophages induce vasculogenic mimicry of glioblastoma multiforme through cyclooxygenase-2 activation.
    Rong X; Huang B; Qiu S; Li X; He L; Peng Y
    Oncotarget; 2016 Dec; 7(51):83976-83986. PubMed ID: 27824617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 in glioblastoma multiforme.
    Qiu J; Shi Z; Jiang J
    Drug Discov Today; 2017 Jan; 22(1):148-156. PubMed ID: 27693715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HNRNPA2B1 stabilizes NFATC3 levels to potentiate its combined actions with FOSL1 to mediate vasculogenic mimicry in GBM cells.
    Wang H; Shi Y; Zhou X; Zhang L; Yang A; Zhou D; Ma T
    Cell Biol Toxicol; 2024 Jun; 40(1):44. PubMed ID: 38862832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.
    Zhu Y; Zhao K; Prinz A; Keyvani K; Lambertz N; Kreitschmann-Andermahr I; Lei T; Sure U
    Neuro Oncol; 2016 Apr; 18(4):538-48. PubMed ID: 26254477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioblastoma-derived tumor cells induce vasculogenic mimicry through Flk-1 protein activation.
    Francescone R; Scully S; Bentley B; Yan W; Taylor SL; Oh D; Moral L; Shao R
    J Biol Chem; 2012 Jul; 287(29):24821-31. PubMed ID: 22654102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-targeting NGR-modified liposomes recognizing glioma tumor cells and vasculogenic mimicry for improving anti-glioma therapy.
    Huang D; Zhang S; Zhong T; Ren W; Yao X; Guo Y; Duan XC; Yin YF; Zhang SS; Zhang X
    Oncotarget; 2016 Jul; 7(28):43616-43628. PubMed ID: 27283987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CECR1-mediated cross talk between macrophages and vascular mural cells promotes neovascularization in malignant glioma.
    Zhu C; Chrifi I; Mustafa D; van der Weiden M; Leenen PJM; Duncker DJ; Kros JM; Cheng C
    Oncogene; 2017 Sep; 36(38):5356-5368. PubMed ID: 28534507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR2-Expressing Tumor Cells Drive Vascular Mimicry in Antiangiogenic Therapy-Resistant Glioblastoma.
    Angara K; Borin TF; Rashid MH; Lebedyeva I; Ara R; Lin PC; Iskander A; Bollag RJ; Achyut BR; Arbab AS
    Neoplasia; 2018 Oct; 20(10):1070-1082. PubMed ID: 30236892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dying glioma cells establish a proangiogenic microenvironment through a caspase 3 dependent mechanism.
    Feng X; Yu Y; He S; Cheng J; Gong Y; Zhang Z; Yang X; Xu B; Liu X; Li CY; Tian L; Huang Q
    Cancer Lett; 2017 Jan; 385():12-20. PubMed ID: 27826040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA HULC stimulates the epithelial-mesenchymal transition process and vasculogenic mimicry in human glioblastoma.
    Yin T; Wu J; Hu Y; Zhang M; He J
    Cancer Med; 2021 Aug; 10(15):5270-5282. PubMed ID: 34213079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An miR-340-5p-macrophage feedback loop modulates the progression and tumor microenvironment of glioblastoma multiforme.
    Liu Y; Li X; Zhang Y; Wang H; Rong X; Peng J; He L; Peng Y
    Oncogene; 2019 Dec; 38(49):7399-7415. PubMed ID: 31427735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M2-like tumor-associated macrophages drive vasculogenic mimicry through amplification of IL-6 expression in glioma cells.
    Zhang L; Xu Y; Sun J; Chen W; Zhao L; Ma C; Wang Q; Sun J; Huang B; Zhang Y; Li X; Qu X
    Oncotarget; 2017 Jan; 8(1):819-832. PubMed ID: 27903982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of CYR61 and CTGF by LM98: a synthetic YAP-TEAD inhibitor that targets in-vitro vasculogenic mimicry in glioblastoma cells.
    Roy ME; Veilleux C; Paquin A; Gagnon A; Annabi B
    Anticancer Drugs; 2024 Sep; 35(8):709-719. PubMed ID: 38900643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cox-2-derived PGE2 induces Id1-dependent radiation resistance and self-renewal in experimental glioblastoma.
    Cook PJ; Thomas R; Kingsley PJ; Shimizu F; Montrose DC; Marnett LJ; Tabar VS; Dannenberg AJ; Benezra R
    Neuro Oncol; 2016 Oct; 18(10):1379-89. PubMed ID: 27022132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2.
    Chen L; Wang X; Wang H; Li Y; Yan W; Han L; Zhang K; Zhang J; Wang Y; Feng Y; Pu P; Jiang T; Kang C; Jiang C
    Eur J Cancer; 2012 Nov; 48(16):3104-11. PubMed ID: 22406049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual antivascular function of human fibulin-3 variant, a potential new drug discovery strategy for glioblastoma.
    Ke C; Luo JR; Cen ZW; Li Y; Cai HP; Wang J; Chen FR; Siegel ER; Le KN; Winokan JR; Gibson GJ; McSwain AE; Afrasiabi K; Linskey ME; Zhou YX; Chen ZP; Zhou YH
    Cancer Sci; 2020 Mar; 111(3):940-950. PubMed ID: 31922633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of aquaporin‑1 with tumor migration, invasion and vasculogenic mimicry in glioblastoma multiforme.
    Yang WY; Tan ZF; Dong DW; Ding Y; Meng H; Zhao Y; Xin XF; Bi W
    Mol Med Rep; 2018 Feb; 17(2):3206-3211. PubMed ID: 29257313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase-2 in tumor-associated macrophages promotes breast cancer cell survival by triggering a positive-feedback loop between macrophages and cancer cells.
    Li H; Yang B; Huang J; Lin Y; Xiang T; Wan J; Li H; Chouaib S; Ren G
    Oncotarget; 2015 Oct; 6(30):29637-50. PubMed ID: 26359357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia promotes glioma-associated macrophage infiltration via periostin and subsequent M2 polarization by upregulating TGF-beta and M-CSFR.
    Guo X; Xue H; Shao Q; Wang J; Guo X; Chen X; Zhang J; Xu S; Li T; Zhang P; Gao X; Qiu W; Liu Q; Li G
    Oncotarget; 2016 Dec; 7(49):80521-80542. PubMed ID: 27602954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts.
    Orecchia P; Conte R; Balza E; Pietra G; Mingari MC; Carnemolla B
    Oncotarget; 2015 Nov; 6(35):37426-42. PubMed ID: 26460958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.